ToolGen Opens Testing Facility in Osong for Advanced Research
ToolGen, Inc. (CEO Dr. Jong-Sang Ryu, KOSDAQ: 199800), a pioneer in CRISPR-Cas9 genome-editing technology, ...
ToolGen has launched a new advanced field testing facility in Osong, enhancing its research capabilities. The facility is part of the company's broader strategy to streamline the development of genome-editing technologies. This move supports the transition from laboratory research to real-world applications. The company, known for its work in CRISPR-Cas9, aims to accelerate the commercialization of its innovations. The new site is expected to improve the efficiency of product testing and development. It also strengthens ToolGen's position in the biotechnology sector. The facility is a key step in the company's long-term growth plan. This development highlights the company's commitment to advancing genetic research.
The facility supports the practical application of genome-editing technologies, which could lead to new medical treatments.
📌 Kaynak
Bu özet Indonesia kaynağından otomatik derlenmiştir. Tamamı için orijinal habere gidin.
Orijinal haberi oku →